相关实验视频

Updated: Jun 17, 2025

Artificial Intelligence Approaches to Assessing Primary Cilia

Artificial Intelligence Approaches to Assessing Primary Cilia

Published on: May 1, 2021

肥胖相关的纤维病:专注于生物标志物的进展

Qianwen Zhang¹, Yiguo Huang¹, Shiyang Gao¹

¹Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

International journal of molecular sciences

|August 10, 2024

概括

与肥胖相关的纤毛病,如阿尔斯特罗姆综合征,表现出各种症状. 生物标志物是必要的,以更好地理解和管理这些罕见的遗传疾病,影响主要的毛.

科学领域:

遗传学是一个遗传学.
罕见疾病罕见疾病
生物标志物发现发现

背景情况:

与肥胖相关的纤毛病,包括阿尔斯特罗姆综合征和巴德特-比德尔综合征,是一组罕见的遗传疾病.
这些情况显示出显著的遗传和表型变异性.
了解它们对于阐明初级乳毛在人类健康中的作用至关重要,特别是关于肥胖的问题.

研究的目的:

审查目前肥胖相关的纤毛病领域的进展.
突出生物标志物的潜力,以了解疾病的变异性.
探索生物标志物在临床表现,诊断和预后中的作用.

主要方法:

关于肥胖相关的纤毛病的广泛文献综述.
对遗传和表型数据的分析.
识别潜在的生物标志物候选者.

主要成果:

与肥胖相关的纤毛病症表现出相当多的异质性.
目前的诊断方法依赖于临床和遗传检测.
对于这些疾病的生物标志物研究存在重大差距.

结论:

生物标志物对于解决临床表现,疾病进展和治疗反应的变异性至关重要.
对生物标志物的进一步研究将改善诊断和预后.
了解这些纤毛病症可以了解初级纤毛功能.

关键词:

生物标志物生物标志物纤毛病是一种纤毛病.肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖罕见疾病是一种罕见的疾病.

更多相关视频

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis

Published on: January 31, 2025

相关概念视频

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...